Your session is about to expire
← Back to Search
Betamethasone for Neonatal Hypoglycemia
Study Summary
This trial is investigating whether giving a steroid called betamethasone to late preterm infants before they are born impacts the development of neonatal hypoglycemia.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are pregnant with only one baby.I received betamethasone during my pregnancy.I cannot take betamethasone due to health reasons.You are expecting to give birth a little earlier than expected.The baby has died before birth.Severe birth defectsYou are between 34 weeks and 36 weeks and 5 days pregnant.You have diabetes before becoming pregnant.You are pregnant with twins.
- Group 1: Late Preterm Steroids 2 Days
- Group 2: Late Preterm Steroids 7 Days
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research represent an unprecedented approach?
"Presently, there are 15 ongoing clinical trials for Late Preterm Steroids 7 Days that span 22 countries and 55 cities. These investigations began in 2010 when Mantecorp Industria Quimica e Farmaceutica Ltd conducted a Phase 3 study of 170 patients. Since then, 121 observations have been concluded successfully."
What is the cap on participant numbers for this medical experiment?
"Currently, this trial is not recruiting participants. It was first published on July 1st 2021 and last updated April 29th 2021. If you are looking for other medical trials to join, there are 124 clinical studies actively enrolling patients with hypoglycemia and 15 Late Preterm Steroids 7 Days studies that need volunteers now."
What clinical indications are most typically addressed with treatment utilizing Late Preterm Steroids 7 Days?
"Late Preterm Steroids 7 Days is usually prescribed to alleviate nephrotic syndrome. Additionally, this medication has been used with success for the management of neoplasms, brain disorders, ophthalmia, sympathetic issues and eye afflictions."
Is this research program accepting new participants?
"This clinical trial is not presently admitting participants. It was published on July 1st 2021, and the latest update to its information occurred April 29th of this year. If you are interested in other research studies involving hypoglycemia, 124 trials are actively recruiting patients while 15 more have opened enrollment for Late Preterm Steroids 7 Days."
To what extent has Late Preterm Steroids 7 Days been proven to be innocuous for individuals?
"There is a wealth of evidence supporting the safety of Late Preterm Steroids 7 Days, so it has been rated 3 on our team's scale. This treatment has already taken its final step in development and gained approval."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger